Related Experiment Video

Updated: Jun 17, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Multiple therapeutic effects of adjunctive baicalin therapy in experimental bacterial meningitis

Yong-Jun Tang1, Fu-Wen Zhou, Zi-Qiang Luo

  • 1Department of Pediatrics, Xiangya Hospital, Central South University, Hunan, China.

Inflammation
|December 25, 2009
PubMed

Insights

This study found that baicalin, when used with ampicillin, effectively treats experimental bacterial meningitis in rabbits. Adjunctive baicalin therapy significantly reduced inflammation and improved key health indicators in rabbits with meningitis.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Infectious Diseases

Background:

  • Bacterial meningitis is a serious infection causing inflammation and increased intracranial pressure.
  • Ampicillin is a common antibiotic, but its efficacy in severe meningitis can be limited.
  • Baicalin is a flavonoid with known anti-inflammatory properties.

Purpose of the Study:

  • To investigate the therapeutic effects of adjunctive baicalin therapy combined with ampicillin for experimental bacterial meningitis.
  • To evaluate the impact of this combination on cerebrospinal fluid (CSF) markers, intracranial pressure, and brain water content.

Main Methods:

  • Induction of bacterial meningitis in rabbits using Escherichia coli.
  • Administration of ampicillin alone or in combination with baicalin.
  • Measurement of CSF leukocyte counts, protein, TNF-alpha, IL-1, lactate, brain water content, and arterial/intracranial pressures.

Main Results:

  • Ampicillin alone exacerbated certain meningitis markers.
  • Adjunctive baicalin counteracted ampicillin-induced exacerbation and alleviated inflammatory markers.
  • The combination therapy significantly reduced CSF inflammatory markers, intracranial pressure, and brain water content.

Conclusions:

  • Adjunctive baicalin therapy demonstrates significant therapeutic benefits in experimental bacterial meningitis.
  • Baicalin enhances the effects of ampicillin, offering a promising treatment strategy.
  • This combination therapy presents a multi-faceted approach to managing bacterial meningitis complications.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...